DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the publication of an article related to its Arcelis™ HIV immunotherapy program in the peer-reviewed online journal PLoS ONE. The publication details research on the progression of HIV infection, virulence factors, the immunosuppressive properties of HIV, and how this research may influence the development of HIV immunotherapies.
